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Finding candidate disease genes<p>A novel approach to findi g candidate genes by using gene-expression data has been developed and used to identify a multiple sclerosis susceptibility c ndida e gen s.</p>
Abstract
A novel approach to finding candidate genes by using gene expression data through liquid
association is developed and used to identify multiple sclerosis susceptibility candidate genes.
Background
Studies aiming to identify susceptibility genes in complex dis-
eases have proceeded along two lines. The traditional candi-
date gene approach is limited by our ability to come up with a
comprehensive list of biologically related genes. On the other
hand, the 'hypothesis free' approach relies on genome-wide
scans for disease loci, typically via linkage in exceptionally
large families or via association in case control studies. Mul-
tiple sclerosis (MS), which is one of the most common neuro-
logic disorders affecting young adults, is characterized by
demyelination and reactive gliosis [1]. Analogous to many
complex traits, genome scans in MS have identified numer-
ous chromosomal loci often with only a nominal evidence for
linkage to MS [2-6]. With the notable exception of the human
leukocyte antigen (major histocompatibility complex [MHC])
locus on 6p21, evidence for specific MS genes emerging from
these studies is still scanty. Thus far, the only associated non-
HLA genes replicated in multiple populations are the PRKCA
gene [7] and the recently reported IL2RA and IL7R genes [8].
For MS, as for most complex traits, the loci derived from link-
age scans have remained quite wide because of multiple
uncertainties concerning the disease model in statistical anal-
yses. To expedite the process of gene identification in these
wide DNA regions, we need novel approaches to identify
potentially involved pathways and to prioritize genes on iden-
tified loci for further sequencing efforts.
Our idea is to turn to full genome functional studies for these
goals. As illustrated in Figure 1, our approach takes advantage
of the availability of abundant microarray data and a wealth
of genomic/proteomic knowledge base from the public
domain. Our intention is to integrate information from both
the candidate gene and the full genome scan (thus far mostly
family-based linkage) approaches. In this report we use two
previously reported MS susceptibility genes, identified in the
same study sample [7,9], namely MBP and PRKCA, as the
lead to probe microarray gene expression data for function-
ally associated genes. High score genes, identified by statisti-
cal data analysis, are followed up by an extensive literature
search for their biologic relevance.
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Materials and methods, below). The first two, namely
NCI_cDNA and NCI_Affy, are expression profiles for US
National Cancer Institute (NCI)'s 60 human cancer cell lines
reported by two different research teams [10,11]. The other
two databases, GCN_2002 and GCN_2004, provide expres-
sion profiles for a diverse array of human tissues [12,13].
Together, they offer a glimpse into transcript regulation
under a wide spectrum of physiologic conditions.
In addition to the conventional similarity study, we utilized a
new computational tool, termed liquid association (LA) [14-
16]. The power of the LA method in identifying elements of
biologic pathways has been demonstrated by its use to iden-
tify correctly genes that are involved in the urea cycle [14]. In
conventional similarity analysis, we tend to rely on the corre-
lation corr(X,Y), which measures the degree of co-expression
between two genes X and Y. Genes with high correlations are
likely to be functionally associated. The encoded proteins may
participate in the same pathway, form a common structural
complex, or be regulated by the same mechanism. However,
not all functionally associated genes are co-expressed;
indeed, the majority of them are not. One conceivable reason
for this is that gene expression can be sensitive to the often
varying cellular state, such as presence or absence of hor-
mones, metabolites, ion homeostasis, and so on. Two genes X
and Y that are engaged in a common process under some con-
ditions may disengage and embark on activities of their own
as the cellular state changes. Consequently, two functionally
related genes with a positive correlation in expression may
become uncorrelated or even negatively correlated as the rel-
evant state variable changes. If we could characterize the
mediating state variable, then we might be able to detect the
correlation by controlling the state variable.
Finding the mediating state variable is by no means simple.
LA is a statistical device introduced for this purpose. The
method is based on the assumption that the state variable is
correlated with the expression of a third gene Z. If this is the
case, then we may use Z to detect such a 'liquid' (as opposed
to 'solid') pattern of statistical association between X and Y.
Figure 2 illustrates how LA works. A liquid association score
LA(X, Y|Z) can be computed using a simple statistical for-
mula given in [14]. There are two ways of applying LA. For a
given pair of X and Y, one can look for genes that may mediate
X,Y co-expression by computing the LA score LA(X, Y|Z) for
each gene Z in the genome and obtaining a genome-wide
ranking. Alternatively, given one gene Z, we may ask which
pairs of genes Z may mediate. With more computing effort,
we can obtain LA(X, Y|Z) for every pair of genes X,Y and rank
their scores in order to identify the most significant pairs. We
have constructed a website to facilitate online searching for
genes of interest. (See Additional data file 2 [Supplementary
Text 1] for an illustrative application to the Alzheimer's hall-
mark gene APP [amyloid-β precursor protein].)
Federated functional genomics approachigu e 1
Federated functional genomics approach. The two dashed lines in this 
diagram indicate (a) the candidate gene approach and (b) the full-genome 
scan approach to finding susceptibility genes. Information from both 
approaches is used to guide the functional genomic study on multiple sets 
of microarray gene expression databases. This approach is powered by 
online statistical computation and a biomedical literature search.
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Liquid association. (a) Association between genes X and Y as mediated by 
gene Z. When gene Z is expressed at the high level (red), a positive 
correlation between X and Y is observed. The association changes as the 
expression of Z is lowered. It eventually becomes a negative trend (green). 
There are two basic ways (shown in panels b and c) to apply the liquid 
association (LA) scoring system to guide a genome-wide search. (b) When 
two genes X and Y are given, compute LA score LA(X, Y|Z) for every gene 
Z first and then output a short list of high score genes Z1, Z2, and so on. 
(c) When only one gene X is given, compute LA score LA(X, Y|Z) for 
every pair of genes X,Y first and then output a short list of high score gene 
pairs Y1,Z1, Y2,Z2, and so on.
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MBP-initiated genome-wide liquid association search 
identifies A2M
We started with the MBP gene (which encodes myelin basic
protein, an integral element of the myelin sheath surrounding
the neuronal extensions). This gene is critical in triggering the
immune reaction in the demyelination process for experi-
mental allergic encephalomyelitis (EAE), a rodent model of
MS. Importantly, MBP has been implicated both in linkage
and in association studies conducted in MS pedigrees of Scan-
dinavian origin (see Haines and coworkers [4] for
references).
We applied the second genome-wide LA search method (Fig-
ure 2c) to the NCI_cDNA database. By treating MBP as the
query gene X, we evaluate the LA score for every pair of genes
(Y,Z). Because there are 9,076 genes in this database, about
49 million LA scores are computed and compared with each
other. The output of a short list of 25 gene pairs with the best
LA scores each from the positive and the negative ends is
given in Additional data file 1 (Table S1). The statistical signif-
icance of the results of this gene search procedure is discussed
in Additional data file 2 (Supplementary Text 3). We find that
the gene A2M (encoding α2-macroglobulin, a cytokine
transporter and protease inhibitor) appears many times. We
further find an interesting biologic functional association
between A2M and MBP from some literature about the patho-
genesis of MS. Following demyelination in human MS and
rodent EAE, immunogenic MBP peptides are released into
cerebrospinal fluid and serum (see Oksenberg and coworkers
[2] for references) and A2M represents the major MBP-bind-
ing protein in human plasma [17]. A significant increase in
α2-macroglobulin is found in plasma of MS patients [18].
Analogously, in rodent EAE, infusion of α2-macroglobulin
significantly reduces disease symptoms [19].
Among the genes to which A2M is paired, three are found to
have functional association with immunologic neurodegener-
ative diseases. LYST (lysosomal trafficking regulator, also
known as CHS1) is the causal gene for Chediak-Higashi syn-
drome, an inherited immunodeficiency disease, and CHM
(Rab escort protein 1) is responsible for an inherited human
retinal blindness known as choroideremia. (For details, see
Online Mendelian Inheritance in Man of the National Center
for Biotechnology Information [20].) TRIB2 (tribbles
homolog 2) was identified as an autoantigen in autoimmune
uveitis, a term encompassing a group of ocular inflammatory
disorders with unknown causes [21]. Additionally, MPDZ
(multiple PDZ domain protein) encodes a tight junction pro-
tein that is detected in noncompact regions of myelin, and it
is thought to be required to maintain the cytoarchitecture of
myelinating Schwann cells [22]. The biologic connection for
other genes, many still of unknown function, is not clear. We
compute the correlation between these genes and find that
most of them have significant correlations. (See in Additional
data file 2 [Supplementary Text 4] for more discussion.)
Four multiple sclerosis loci from the Finnish population 
and PRKCA
Four major loci linked to MS have been identified in Finnish
families: HLA on 6p21, MBP on 18q, and loci on 17q22-24 and
5p14-p12 [23]. These loci have also been implicated in other
MS study samples from more heterogeneous populations
[24,25]. The large locus on 17q was further refined to a 3 meg-
abase (Mb) region in the Finnish MS families [23]. However,
little information is available in the literature concerning how
various loci are related to each other biologically. Most
recently, association of specific PRKCA alleles at 17q24 with
MS both in Finnish and Canadian MS study samples has been
reported [7]. Involvement of PRKCA in MS was also validated
by an association reported in a UK population [26]. PRKCA
encodes a regulator of immune response, making it a highly
suitable candidate gene for MS. A potential functional link
between the MBP and PRKCA genes was identified by Feng
and coworkers [27], who showed that a golli product of the
myelin basic protein gene (MBP) can serve as a negative reg-
ulator of signaling pathways in T lymphocytes, particularly
the protein kinase C pathway.
MBP-PRKCA-initiated liquid association search 
identifies SLC1A3
To study the co-expression pattern between MBP and
PRKCA, we took them as genes X and Y to explore the
GNF_2002 database using our system. The gene with the
greatest LA score was the gene SLC1A3 (glial high affinity
glutamate transporter, member 3; see Additional data file 1
[Table S2]). Interestingly, SLC1A3 is located on 5p13.2 (36.6
to 36.7 Mb), within the previously identified MS locus on 5p
[28], which is syntenic to the EAE2 locus in mouse.
Test of the genetic relevance of SLC1A3 to multiple 
sclerosis
We wished to test whether there is any genetic relevance of
SLC1A3 to MS. We selected five single nucleotide polymor-
phisms (SNPs) flanking the SLC1A3 gene (Table 1) to be gen-
otyped in our primary study set, consisting of 61 MS families
from the high-risk region of Finland. The most 5' SNP,
namely rs2562582, located within 2 kilobases from the initi-
ation of the SLC1A3 transcript, exhibited initial evidence for
association with MS (P = 0.005) in the transmission disequi-
librium test (TDT) analysis, suggesting a possible functional
role for this variant in the transcriptional regulation of this
gene. Moreover, as shown in Table 1, stratification of the
Finnish MS families according to HLA genotype (using the
SNP rs2239802, which exhibited strongest evidence for asso-
ciation in the Finnish families in the report by Riise Stensland
and coworkers [28]), strengthened the association between
the SLC1A3 SNP and MS (P = 0.0002, TDT). Thus, based on
LA, and supported by association analyses in an MS study
sample, the presence of SLC1A3 serves as a potential candi-
date to connect all four major MS loci identified in Finnish
families, elucidating a potential functional relationshipGenome Biology 2007, 8:R205
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further evidence in the following discussion.
Further liquid association analyses
We next took MBP and SLC1A3 as the query genes to conduct
a genome-wide LA search in all four gene expression data-
bases. Figure 3 and Table 2 highlight a set of genes whose bio-
logic functions are most relevant to our MS study according to
the literature. The detail LA outputs are given in Additional
data file 1 (Tables S3 to S6). All LA plots are easy to generate
online using our website. The one for the triplet including
MBP, PRKCA, and SLC1A3 is shown in Figure 4.
For GNF_2002 data, the gene with greatest LA score is GRM3
(glutamate receptor, metabotropic 3), followed by several
genes involved in nervous diseases and neural development/
functioning: GFAP, CDR1, ROM1, CACNA1A, and GRIA3. We
also find IL7R, IGHG3, IGLJ3, and HLA-A among the highest
scoring genes in this query. The identification of the IL7R by
the LA analysis is particularly interesting because this gene
was found to be associated with MS in the recent large inter-
national Whole Genome Association study [8].
MBP-SLC1A3 initiated LA search identifies the HLA 
locus on 6p21
The locus of HLA on 6p21 is the only consensus MS locus rep-
licated by genetic studies across different populations.
Importantly, in the recent fine mapping effort with 1,068
SNPs covering the HLA locus and providing the SNP density
of 1 SNP per 2 kilobases in the study sample of 4,200 individ-
uals from Finnish and Canadian MS families [29], suscepti-
bility to MS proved to be determined by HLA-DRB1 alleles
and their interactions. Therefore, it is especially interesting
that for the GNF_2004 data, eight of the 25 genes with the
best LA scores are from the HLA locus: HLA-A (twice), HLA-
B (twice), HLA-C (twice), and HLA-G (twice). Other HLA
genes with very high LA scores include HLA-E, HLA-F, HLA-
DRA, and HLA-DPB1. We also find B2M (which encodes β2-
microglobulin, the light chain of MHC class I antigen) and a
MS susceptibility gene, namely CD45 (a T-cell receptor for
galectin-1).
Additional functionally associated genes detected
The LA lists from NCI_cDNA data and NCI_Affy data also
yielded several highly relevant candidate genes for MS, such
as MAG, IRF1, APOE, EIV2A, and PDGFA. Also of interest are
SIAT8A, SIAT1, SOX4, SOX9, and EPHA2. The protein
encoded by MAG (myelin-associated glycoprotein) is
involved in the process of myelination [30] and binds to sialic
acid. SIAT1 and SIAT8A are both sialyltransferases. SOX4
and SOX9 are involved in central nervous system develop-
ment [31,32]. SOX4 is required for the development of lym-
phocytes and thymocytes [33].
Results from the two NCI datasets also contain genes from the
6p21.3 locus: TAP2, TRIM10, and HLA-DQB1. A further
investigation into the expressional association of the HLA
family with SLC1A3 using the LA method finds two highly sig-
nificant genes, namely GMFB and PDGFRA (see Additional
data File 1 [Tables S7 and S8]). Also, these genes are be bio-
logically relevant. GMFB (which encodes glia maturation fac-
tor beta) is reported to increase in astrocytes around the
lesioned area after cortical cryogenic brain injury [34]. PDG-
FRA (the gene encoding platelet-derived growth factor recep-
tor-α) is a well known marker for remyelination. The PDGFA
supply may control oligodendrocyte progenitor cell numbers
in the adult central nervous system as well as during develop-
ment [35]. Interestingly, CTNND2 (catenin delta 2; neural
plakophilin-related arm-repeat protein) is the fifth most cor-
related gene for SLC1A3 in the GNF_2004 data (see Addi-
tional data file 1 [Table S9]). It is also highly correlated with
MBP (see Additional data file 1 [Table S10]).
Discussion
We here introduce a novel bio-computational approach to
identifying new candidate genes for genetic and functional
studies of complex human traits. The initial result from the
Table 1
Genetic association results for SNPs located in the SLC1A3 gene in Finnish multiple sclerosis families
All families (n=69) and HLA stratified (n=38)
SNP ID TDT, P value TDT, P value MAF (CEPH) MAF (Finnish)
rs2562582 0.005 0.0002 0.175 0.169
rs10941306 0.344 0.5 0.317 0.378
rs1366632 0.49 0.4898 0.458 0.459
rs1544795 0.477 0.5 0.467 0.437
rs1549627 0.5 0.4765 0.44 0.45
MAF (CEPH) is the minor allele frequency, as calculated from genotyping 30 trios belonging to Centre d'Etude du Polymorphisme Humain (CEPH) 
panel by HapMap project. MAF (Finnish) is the minor allele frequency calculated from genotyping the Finnish families used in this study. The 
transmission disequilibrium tests (TDTs) were calculated using ANALYZE software package [48]. In all, 69 families are included in this analysis, of 
which 38 are HLA stratified (multiple sclerosis families in which the affected individual had one or two HLA single nucleotide polymorphism [SNP] 
2239802 risk alleles).Genome Biology 2007, 8:R205
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two genes, MBP and PRKCA, as the lead to probe for
functionally associated genes, the LA method was successful
in identifying a number of potential MS-related genes
through subtle transcription co-regulation under a wide spec-
trum of cellular conditions. Additionally, when MBP and
SLC1A3 were used as query genes in the LA analysis, the
recently identified MS susceptibility gene IL7R was among
the highest scoring, statistically significant genes.
LA allows the detection of gene co-regulation, which may only
occur under specific cellular states. There is no need to specify
Table 2
Genes detected in the liquid association analysis shown in Figure 1
Gene ID Location Description
MBP 18q23* Myelin basic protein
PRKCA 17q24.2* Protein kinase C, alpha
SLC1A3 5p13.2† Solute carrier family 1 (glial high affinity glutamate transporter), member 3
A2M 12p13.31* α2-Macroglobulin
GRM3 7q21.12 Glutamate receptor, metabotropic 3
GFAP 17q21.31 Glial fibrillary acidic protein
CDR1 Xq27.1 Cerebellar degeneration-related protein 1, 34kDa
ROM1 11q12.3 Retinal outer segment membrane protein 1
CACNA1A 19p13.2 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
GRIA3 Xq25 Glutamate receptor, ionotrophic, AMPA3
SOX21 13q32.1 SRY (sex determining region Y)-box 21
IL7R 5p13.2† Interleukin 7 receptor
IGHG3 14q32.33* Immunoglobulin heavy constant gamma 3 (G3m marker)
IGLJ3 22q11.1 Immunoglobulin lambda joining 3
HLA-A 6p21.33† Major histocompatibility complex, class I, A
HLA-B 6p21.33† Major histocompatibility complex, class I, B
HLA-C 6p21.33† Major histocompatibility complex, class I, C
HLA-G 6p22.1† HLA-G histocompatibility antigen, class I, G
B2M 15q21.1 β2-Microglobulin
PTPRC 1q31.3* Protein tyrosine phosphatase, receptor type, C
EVI2A 17q11.2* Ecotropic viral integration site 2A
TAP2 6p21.32* Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
TRIM10 6p21.33† Tripartite motif-containing 10
SIAT1 3q27.3 Sialyltransferase 1 (beta-galactoside alpha-2,6-sialyltransferase)
MAG 19q13.12* Myelin associated glycoprotein [M29273]
IRF1 5q23.3* Interferon regulatory factor 1
APOE 19q13.31* Apolipoprotein E
PDGFA 7p22* Platelet-derived growth factor-α polypeptide [H89357]
SIAT8A 12p12.1 Sialyltransferase 8A
SOX4 6p22.3† SRY (sex determining region Y)-box 4
SOX9 17q24.3† SRY (sex determining region Y)-box 9
HLA-DQB1 6p21.32† Major histocompatibility complex, class II, DQ beta 1
EPHA2 1p36.13 EphA2 [T74614]
GMFB 14q22.2 Glia maturation factor, beta
PDGFRA 4q12* Platelet-derived growth factor receptor-α polypeptide [M21574]
PLP1 Xq22.2* Proteolipid protein 1
KLK6 19q13.41 Kallikrein 6 (neurosin, zyme)
PMP2 8q21.13 Peripheral myelin protein 2
CTNND2 5p15.2* Catenin delta 2 (neural plakophilin-related arm-repeat protein)
NTRK2 9q21.33 Neurotrophic tyrosine kinase, receptor type 2
PKP4 2q24.1 Plakophilin 4
*Genes previously reported associated with MS. †Genes located within the previously reported MS susceptibility loci.Genome Biology 2007, 8:R205
http://genomebiology.com/2007/8/10/R205 Genome Biology 2007,     Volume 8, Issue 10, Article R205       Li et al. R205.6the states, and this is one of the advantages of LA [14]. Fur-
thermore, LA can be used in conjunction with traditional cor-
relation analysis. An online computation system to conduct
both LA and correlation analysis is available at our website
[36]. This platform allows users to switch conveniently from
one gene expression dataset to another. Those conducting
research in other diseases can easily carry out analyses
similar to that presented here with a few leading genes related
to the disease of interest.
Glutamate-induced excitotoxicity
Although all of the putative genes identified using LA method
must be confirmed with genetic association studies in multi-
ple populations and eventually in targeted functional studies,
the putative genes identified here are highly relevant to MS.
Our transcript regulatory findings portray a coherent web of
molecular evidence, which supports the glutamate-induced
excitotoxicity hypothesis of MS. SLC1A3 is highly expressed
in various brain regions including cerebellum, frontal cortex,
basal ganglia, and hippocampus. It encodes a sodium-
dependent glutamate/aspartate transporter 1 (GLAST).
Glutamate and aspartate are excitatory neurotransmitters
that have been implicated in a number of pathologies the
nervous system. Glutamate concentration in cerebrospinal
fluid rises in acute MS patients [37], whereas the glutamate
antagonist amantadine reduces MS relapse rate [38]. In EAE,
the levels of GLAST and GLT-1 (SLC1A2) have been reported
to be downregulated in spinal cord at the peak of disease
symptoms, and no recovery was observed after remission
[39]. We consider it encouraging that several lines of evi-
dence, including both genetic association and gene expres-
sion association, are consistent with the glutamate-induced
excitotoxicity hypothesis, which states that glutamate-
induced excitotoxicity results in demyelination and axonal
damage in MS [40].
International multiple sclerosis Whole Genome 
Association study
The recent international MS Whole Genome Association scan
[8] provided additional evidence supporting an association
between MS susceptibility and SLC1A3. A major component
of the study is the use of Affymetrix 500K to screen common
genetic variants of 931 family trios. Using the online supple-
mentary information provided by the International MS
Genetics Consortium [8] we found two SNPs, namely
rs4869676 (chromosome 5: 36641766) and rs4869675 (chro-
mosome 5: 36636676), with TDT P values of 0.0221 and
0.00399, respectively, which are in the upstream regulatory
SLC1A3 and related genesFigure 3
SLC1A3 and related genes. Four large-scale gene expression databases are 
used in this study. The arrows point to the genes found using the liquid 
association score system, according to the search method described in 
Figure 2b. The color of a line/arrow shows which database is used in the 
analysis. P values are calculated by randomization test. For descriptions of 
gene symbols, see Table 2. All four major multiple sclerosis loci for the 
Finnish scan have representative genes in this chart: MBP from 18q23, 
PRKCA from 17q22-q23.2, SLC1A3 from 5p13, and the HLA locus at 6p21.3. 
Also shown are two separate lists of genes correlated with MBP and with 
SLC1A3 most strongly. CTNND2 (located at 5p15.2) is seen in both lists.
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Liquid association activity plot for MBP, PRKCA as mediated by SLC1A3Figure 4
Liquid association activity plot for MBP, PRKCA as mediated by SLC1A3. 
When SLC1A3 is upregulated (red squares), a positive association between 
MBP and PRKCA can be seen. The correlation vanishes when the 
expression of SLC1A3 is low (green dots). Liquid association measures the 
change in the correlation structure; the score is 0.438 for this triplet.
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rs486975 there are a total 206 SNPs in the Affymetrix 500K
chip. No other SNPs have P values less than that of rs486975.
The next most significant SNPs in this region are
rs1343692(chromosome 5: 35860930) and rs6897932 (chro-
mosome 5: 35910332; the identified MS susceptibility SNP in
the IL7R axon). The MS marker we identified, rs2562582
(chromosome 5: 36641117), less than 5 kilobases away from
rs4869675, was not used in the Affymetrix chip.
Although the results reported here should be considered pre-
liminary, we propose that the genes and networks identified
should be targets for additional analyses of MS in different
study populations.
Use of public gene expression data
One unique feature of our approach to finding candidate
genes is the use of public domain gene expression databases,
of which the original experiments were not designed to study
our disease of interest. For example, the two NCI-60 cell line
(a panel of 60 diverse human cancer cell lines) gene expres-
sion data have primarily been used to aid anticancer drug
screening, not for the study of MS. With our promising initial
findings, we expect our functional genomics approach to be
applicable in the initial identification of involved molecular
pathways in the pathogenesis of other complex diseases.
Investigators may apply our LA method or bring in other
computational methods to data mine the numerous free pub-
lic gene expression databases, thus reducing the time and
expense associated with disease gene identification.
Materials and methods
Gene expression datasets
Four large-scale gene expression databases are employed in
this study, with various numbers of conditions and genes. The
first two databases give expression profiles for the 60 repre-
sentative cell lines from seven cancer types that have been
used in NCI's anticancer drug screen. The NCI_cDNA data-
base uses the cDNA microarray reported by investigators
from P Brown's laboratory at Stanford University [10],
whereas the NCI_Affy uses Affymetrix oligonucleotide high-
density HU6800 arrays [11]. The two other databases [12,13]
are samples from diverse array of human tissues. GNF_2002
has a probe set for a total of 12,533 genes/clones and 101 chips
(using Affymetrix U95A arrays) and GNF_2004 has a probe
set for 33,689 genes and 158 chips (using Affymetrix HG-
U133A and GNF1H; data downloaded from the Gene Expres-
sion Atlas [41]). The corresponding numbers for NCI_Affy
are 5,611 and 60 (data downloaded from the supplementary
data file of Staunton and coworkers [42]), and for NCI_cDNA
they are 9,703 and 60 (data downloaded from the NCI60
Cancer Microarray Project) [43].
Liquid association
To compute the liquid association score LA(X, Y|Z) for a tri-
plet of genes, normal score transformation is first applied for
each gene. After transformation, LA(X, Y|Z) is given by the
average of triple product between X, Y and Z: LA(X, Y|Z) =
(x1y1z1 + ... xmymzm)/m. For a given pair (X,Y), the test of sig-
nificance of an LA score is conducted by permutation, as pre-
viously described [14,16] and the P value is reported in each
of our LA output tables. In addition, to help with the interpre-
tation of the effect size of the LA score, two algorithms were
used to find the correlation change between the state of high
expression of the LA scouting gene and the state of low
expression (see Additional data file 2 [Supplementary Text
5]). The LA website [36] was created to facilitate the online
computation of LA. High score output genes are returned to
user's browser for immediate connection to Entrez Gene. The
website also generates LA graphs, performs standard
correlation analysis, and provides summary information
regarding gene location, functional annotation, and so on.
Multiple sclerosis association study sample
The study set used for the association analysis contained 28
multiplex MS families with multiple affected individuals, and
41 nuclear MS families (MS patient and his/her parents and,
in case of a missing parent, healthy siblings were included).
Twenty-two of the 28 multiplex families and all trio families
originated from Southern Ostrobothnia region of Finland,
which has an especially high incidence and prevalence of MS.
All families were Finnish and of Caucasian descent, and they
have been described in more detail by Saarela and coworkers
[23]. Diagnosis of MS in affected individuals strictly followed
Poser's diagnostic criteria [44]. All individuals gave informed
consent and the study was approved by the Ethics Committee
for Ophthalmology, Otorhinolaryngology, Neurology, and
Neurosurgery in the Hospital District of Helsinki and Uusi-
maa. (decision 46/2002, DNRO 192/E9/02).
Genotyping
To control for sample mix-ups, all samples were genotyped
for determining the sex and four microsatellite markers using
the ABI 3730 (Applied Biosystems, Foster City, CA, USA). The
data were compared with the known sex of the samples and
checked for Mendelian errors. No Mendelian discrepancies
were observed in this study set. To select the initial set of
SNPs used for the association analysis, we set up the following
criteria: each of the markers should be highly polymorphic in
Centre d'Etude du Polymorphisme Humain (CEPH) refer-
ence families genotyped in the HapMap project and should
belong to unique solid line linkage disequilibrium haplotype
blocks as defined by Haploview's version 3.11 [45]. We found
five highly polymorphic SNPs within and in the proximity of
SLC1A3 gene that belonged to separate haplotype blocks,
according to the HapMap data. The SNPs were genotyped
using multiplexed allele-specific primer extension on micro-
arrays [46]. Primers for multiplex polymerase chain reactions
were designed using in-house scripts written for the Primer3Genome Biology 2007, 8:R205
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Snapper, version 1.38beta, was utilized to call genotypes
automatically.
Statistical analyses for genotyping
Allele and genotype frequencies were determined from the
data, and deviation from the Hardy-Weinberg equilibrium
was tested using Pearson's χ2 test. We used the ANALYZE
package to conduct TDT analyses to test for association
between MS and SLC1A3 gene [48].
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